Welcome to our dedicated page for Celsius Hldgs news (Ticker: CELH), a resource for investors and traders seeking the latest updates and insights on Celsius Hldgs stock.
Celsius Holdings, Inc. (CELH) delivers energy drinks backed by clinical research and strategic partnerships in the active lifestyle sector. This page aggregates official press releases and verified news about financial performance, product innovations, and market expansion efforts.
Investors and industry observers will find timely updates on earnings reports, distribution agreements like the PepsiCo collaboration, and new product launches including functional beverage formats. All content is sourced directly from company filings and authorized channels to ensure accuracy.
Key coverage areas include quarterly financial results, international expansion into markets like Europe and Asia-Pacific, scientific developments supporting Celsius' metabolism-boosting claims, and retail distribution milestones. Bookmark this page for streamlined access to CELH's evolving position in the $250B global non-alcoholic beverage market.
The Palm Tree Music Festival returns to Westhampton, NY, on June 24, 2023, headlined by Calvin Harris and Kygo. This festival is presented by CELSIUS ESSENTIAL ENERGY and features artists like Loud Luxury and Sam Feldt. Tickets will be available starting April 20, 2023, with general admission prices beginning at $299. The festival promises an elevated tropical lifestyle experience, offering unique summer vibes and premium beverage sponsorships from Tequila Don Julio and CELSIUS. As a part of Palm Tree Crew, founded by Kygo and Myles Shear, this event looks to merge music and a luxurious environment, showcasing a revamped experience after the successful inaugural event in Aspen.
FSD Pharma Inc. (NASDAQ: HUGE) has appointed Gerry David to its Advisory Board. David, known for his transformative leadership at Celsius Holdings (NASDAQ: CELH), drove a 35-fold increase in shareholder value during his tenure. He is expected to leverage his extensive experience to enhance FSD Pharma's strategies, particularly in developing innovative solutions for alcohol misuse. The company is focused on advancing its pharmaceutical pipeline, including FSD201 for inflammatory diseases and other compounds targeted at mental health and neurodegenerative disorders. Investors may view this appointment as a positive step towards growth and commercialization of new products.
FAQ
What is the current stock price of Celsius Hldgs (CELH)?
What is the market cap of Celsius Hldgs (CELH)?
